
GC15772
Darifenacin HBr
Also known as 2-[(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide;hydrobromide
Darifenacin HBr (UK-88525 hydrobromide) is a selective M3 muscarinic receptor antagonist with pKi of 8·9
ChemicalCAS133099-07-7MW507.48FormulaC28H31BrN2O2
- CAS number
- 133099-07-7
- Molecular weight
- 507.48
- Formula
- C28H31BrN2O2
- Solubility
- ≥ 20·2mg/mL in DMSO
- InChIKey
- UQAVIASOPREUIT-VQIWEWKSSA-N
- Catalogue number
- GC15772
- Brand
- GLPBIO
Computed properties PubChem CID 444030 · TPSA 55.6 Ų · H-bond donors 2 · H-bond acceptors 3
- TPSA
- 55.6 Ų
- H-bond donors
- 2
- H-bond acceptors
- 3
- Rotatable bonds
- 7
- Heavy atoms
- 33
SMILES C1CN(C[C@@H]1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5.Br
Computed descriptors from PubChem (CID 444030), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il